USPTO Patent Application: PDU Sequence Number Synchronization in Wireless Communications

The USPTO has published a new patent application (US20260088935A1) detailing methods for protocol data unit (PDU) sequence number synchronization in wireless communications. The application describes systems and devices that allow user equipment (UE) to reset its protocol data convergence protocol (PDCP) window more efficiently, potentially improving data handling in wireless networks.

Patent Application for Avoiding Obsolete Wireless Transmissions

The USPTO has published a new patent application (US20260088936A1) detailing a method and apparatus for avoiding unnecessary wireless transmissions. The application describes a system where a transmitter node can identify and indicate obsolete packets to a receiver node, aiming to improve network efficiency.

Sony Patent for Communication Devices and Error Correction

The USPTO has published a new patent application from Sony Group Corporation for communication devices and methods. The application details a system for improving data transmission reliability through error correction and retransmission techniques.

Wireless communication node method and device patent application

The USPTO has published a new patent application (US20260088938A1) from Apogee Networks, LLC, detailing a method and device for wireless communications. The application focuses on optimizing signal transmission and resource allocation in wireless nodes.

Patent Application: Communication Method Using Multiple Panels

The USPTO has published a new patent application (US20260088939A1) for a communication method and apparatus using multiple panels. The application, filed by the Electronics and Telecommunications Research Institute, details a terminal's method for receiving and transmitting HARQ-ACK information to a base station.

Radio Transceiver Data Transmission with Error Detection

The USPTO has published a new patent application (US20260088941A1) by Nordic Semiconductor ASA detailing a radio transceiver device for data transmission with enhanced error detection. The application describes a method for transmitting data packets and receiving acknowledgments to retransmit only the blocks that were not successfully received.

5G Joint Transmission Codebook Patent Application

The USPTO has published a patent application (US20260088948A1) detailing techniques for a Type-II coherent joint transmission codebook for 5G networks. The application describes methods for user equipment to determine and report coefficients for a shared codebook structure used by multiple transmission and reception points.

Patent Application: Communication Method and Apparatus

The USPTO has published a patent application (US20260088955A1) detailing a new communication method and apparatus. The invention focuses on increasing the quantity of pilot subcarriers used in data transmission, potentially enhancing communication efficiency.

LG Electronics Patent on Uplink Wireless Communication Transmission

The USPTO has published a new patent application from LG Electronics detailing a method and device for uplink transmission and reception in a communication system. The application, filed on September 19, 2023, describes specific configurations for transmitting PTRS (Phase Tracking Reference Signal) based on DCI (Downlink Control Information) fields.

Patent Application: Base Station, Terminal, and Communication Method

The USPTO has published a new patent application (US20260088958A1) from Panasonic Intellectual Property Corporation of America. The application describes a base station, terminal, and communication method designed to improve transmission efficiency in unlicensed bands by coordinating cyclic prefix lengths.

HUAWEI patent reduces uplink signal interference

The USPTO has published a new patent application from HUAWEI Technologies Co., Ltd. for a communication method and apparatus designed to reduce uplink signal interference. The patent aims to improve communication performance by managing virtual PCI conflicts.

Patent Application for User Equipment, Base Stations, and Methods

The USPTO has published a new patent application detailing user equipment, base stations, and methods for wireless communication. The application, filed on October 31, 2023, describes specific configurations for message handling and data transmission in cellular networks.

Patent Application: Control Channel Resource Identification for Transmission

The USPTO has published a patent application detailing a method for identifying a control channel resource for transmitting physical uplink control channel (PUCCH) information. The application, filed by inventors Mostafa Khoshnevisan, Peter Gaal, and Jing Sun, focuses on optimizing wireless communication by associating PUCCH resources with specific physical downlink control channel (PDCCH) candidates.

VIVO patent: CSI transmission method and apparatus

The USPTO has published a new patent application from VIVO MOBILE COMMUNICATION CO., LTD. for a Channel State Information (CSI) transmission method and apparatus. The application details a method for sending CSI reports where the mapping order of CSI data is determined by specific network configurations or reported content.

UE Spatial Relation Activation and Indication Patent Application

The USPTO has published a patent application (US20260088963A1) detailing methods and apparatuses for user equipment (UE)-initiated spatial relation activation and indication. The application describes a UE receiving TCI state information, activation times, and then transmitting a channel to signal these activation times.

Patent Application for Optimizing Application Resource Usage

The USPTO has published a patent application detailing methods for optimizing application resource usage in network traffic management systems. The application, filed by Vinod Pisharody, describes a system that monitors resource allocation for application functions and adjusts them upon application restart based on historical data.

Sunscreen Compositions and Methods of Use

The USPTO has published a patent application from Mary Kay Inc. detailing new sunscreen compositions designed to protect skin from UV radiation. The application describes specific formulations involving film formers and organic UV filters, along with methods of making and using these compositions.

KAO CORPORATION patent for hair treatment agent

The USPTO has published a patent application by KAO CORPORATION for a hair treatment agent. The application, filed on May 31, 2023, details a specific formulation involving film-forming polymers and organopolysiloxanes.

Cannabis Products and Methods Patent Application

The USPTO has published a patent application (US20260083661A1) for cannabis-based products and methods, including lotions, soaps, perfumes, and teas. The application was filed on October 7, 2025, and lists Lawrence Lanier Long as the inventor.

Oxazolidinone Liposome Compositions with Improved Storage Stability

The USPTO has published a new patent application from Akagera Medicines, Inc. detailing oxazolidinone liposome compositions designed for improved storage stability. The application, filed on December 2, 2025, describes methods for manufacturing and using these compositions.

High-Bioactivity Goat Colostrum Powder Preparation Method

The USPTO has published a patent application detailing a method for preparing a high-bioactivity goat colostrum composite freeze-dried powder. The invention focuses on enhancing the stability and survival rate of probiotics within the powder through encapsulation techniques.

Patent for Spray-Dried Amorphous Solid Dispersions Using Polyvinyl Alcohol

The USPTO has published a new patent application (US20260083676A1) detailing a method for preparing spray-dried amorphous solid dispersions of active pharmaceutical ingredients using polyvinyl alcohol. The application was filed on September 14, 2023, by inventors Lena Mueller, Laura Halstenberg, Thomas Kipping, and Nicole Di Gallo.

Patent Application: Solid Medicinal Forms with Stabilised Active Ingredient

The USPTO has published a new patent application (US20260083677A1) from Astellas Pharma Inc. The application describes solid medicinal forms containing active ingredients stabilized with specific drying agents, aiming for reduced moisture content. This is a new patent filing, not a regulatory rule or guidance.

Oral GLP-1 Compound Dosing Patent Application

The USPTO has published a patent application (US20260083678A1) related to oral dosing of GLP-1 compounds. The application was filed on December 3, 2025, by inventors Flemming S. Nielsen and Per Sauerberg, and relates to improved uses of GLP-1 peptides in oral therapy.

Adagrasib Solid Pharmaceutical Compositions for Treating Cancer

The USPTO has published a new patent application (US20260083679A1) detailing solid pharmaceutical compositions containing adagrasib for treating cancer. The application, filed on December 3, 2025, includes methods for manufacturing these compositions and treating cancer.

Mesoporous Nano-Magnesium Oxide for Drug Loading

The USPTO has published a patent application for a mesoporous nano-magnesium oxide material designed for drug loading. The application details the material's properties, including particle size and pore structure, and outlines a preparation method involving magnesium oxalate and CTAB.

Patent Application: Spray Dried Lipid Nanoparticle Formulations

The USPTO has published a patent application (US20260083681A1) detailing formulations for spray-dried lipid nanoparticle matrix particles. The application, filed on September 16, 2025, describes a composition including lipid nanoparticles, a buffer system, and a barrier matrix stabilizer. This publication is part of the patent application process and does not represent a final grant or regulatory requirement.

Kit for Drug-Containing Nanoparticles and Composition for Drug Delivery

The USPTO has published a new patent application (US20260083682A1) by SAMYANG HOLDINGS CORPORATION for a kit and composition for constructing drug-containing nanoparticles for enhanced drug delivery. The application details a method utilizing cationic compounds and anionic polymers to improve cellular drug delivery efficiency.

Protein Nanospheres for Treating Chemotherapy Dysfunction

The USPTO has published a patent application (US20260083683A1) for protein nanospheres designed to treat dysfunction caused by chemotherapy and immunosuppressive therapy. The application details the manufacture and use of fibrinogen-coated albumin spheres (FAS) and High-Fibrinogen Spheres (HFS) for mitigating toxic effects of cancer treatments.

Anti-GPRC5D Antibody for Cancer Treatment

The USPTO has published a patent application (US20260085114A1) filed by Kyinno Biotechnology Co., Ltd. The application describes an anti-G protein-coupled receptor family class C group 5 member D (GPRC5D) antibody or fragment thereof for the treatment of tumors or cancers. It also details a bispecific antibody targeting GPRC5D and CD3.

CD3 Binding Antibodies Patent Application Inventors Listed

The USPTO has published a new patent application, US20260085115A1, related to CD3 binding antibodies. The application, filed on June 2, 2025, lists inventors Nathan Trinklein, Wim van Schooten, Shelley Force Aldred, Katherine Harris, and Duy Pham.

Patent Application: Antibody Heavy Chain Regions Reduce Fc Gamma Receptor Binding

The USPTO has published a patent application (US20260085116A1) detailing antibody heavy chain constant regions modified to reduce binding to Fc gamma receptors. This modification, achieved through specific residue replacements or deletions in the hinge region, aims to decrease effector functions in antibodies and Fc fusion proteins.

Antibodies with chimeric constant domains reduce effector functions

The USPTO has published a patent application (US20260085117A1) detailing antibodies with chimeric constant domains designed to reduce effector functions. The application, filed on November 24, 2025, describes recombinant polypeptides and methods for their production.

Anti-CTLA-4 Antibody Conjugate Activated by Tumor Microenvironment

The USPTO has published a patent application (US20260085118A1) for a novel conjugate of an anti-CTLA-4 antibody activated by the tumor microenvironment. The application details a dual-activated conjugate designed to improve targeting efficacy, overcome drug resistance, and reduce toxicity.

Patent Application for Treating Cancer with Anti-CTLA4 Antibodies

The USPTO has published a new patent application (US20260085119A1) from ADAGENE PTE. LTD. for methods of treating cancers using anti-CTLA4 antibodies. The application details compositions and treatment methods, including combination therapies for cancers resistant to PD-1 or PD-L1 inhibitors.

Patent Application: Cancer Treatment Compositions and Methods

The USPTO has published a new patent application (US20260085120A1) for compositions and methods related to cancer treatment. The application describes binding agents, carrier proteins, and therapeutic agents, particularly for cancers expressing PD-LI or PD-L2, and lyophilized compositions.

Patent Application: Detecting Pancreatic Cancer

The USPTO has published a patent application (US20260085360A1) detailing methods for detecting pancreatic cancer. The application describes a method involving measuring CA19-9 levels alongside other markers like OPN, MIA, and CEACAM-1 in a subject's sample.

DARPIN Compositions for Treating Shiga Toxin Diseases

The USPTO has published a patent application (US20260085097A1) detailing DARPIN-containing compositions for treating Shiga toxin diseases. The application highlights the thermostability and high microbial expression yield of DARPin as advantages over antibody therapeutics.

Patent Application: Method for Acute Respiratory Distress Syndrome Treatment

The USPTO has published a new patent application (US20260085098A1) from Revolo Biotherapeutics Limited for a method to treat acute respiratory distress syndrome. The application details a treatment method involving the administration of a specific peptide molecule during or in response to a relapse to induce remission.

Process for Isolating Osteopontin and Glycomacropeptide from Whey

The USPTO has published a new patent application (US20260085099A1) detailing a process for isolating osteopontin (OPN) and glycomacropeptide (GMP) from whey. The application, filed on September 15, 2023, describes a chromatography-based method for purification.

Patent Application for Genome Editing Compositions and Methods

The USPTO has published a new patent application (US20260083860A1) for genome editing compositions and methods. The application, filed on August 19, 2025, by inventors Oscar ALVAREZ, Ming-Yue LEE, and Blair B. MADISON, details methods and compositions for functional genetic modifications.

CRISPR Methods Targeting CD70 Expression for Engineered Cells

The USPTO has published a patent application (US20260083861A1) filed by Editas Medicine, Inc. The application describes CRISPR-related systems and methods for targeting the CD70 gene expression in engineered cells, particularly T cells, for potential therapeutic applications.

Patent Application: Treating Brain Diseases with rAAV Particles

The USPTO has published a new patent application (US20260083862A1) from the University of Iowa Research Foundation detailing methods for treating brain diseases using rAAV particles administered via the cisterna magna. The application was filed on May 19, 2025.

Patent Application for Contrast Agents in Diagnostic Imaging

The USPTO has published a patent application (US20260083864A1) for a new class of compounds intended for use as contrast agents in diagnostic imaging, including computed tomography (CT) and magnetic resonance imaging (MRI). The application details specific compound formulas, metal chelates, and preparation methods.

USPTO Patent Application for PSMA Ligands

The USPTO has published a new patent application (US20260083865A1) filed by 3B Pharmaceuticals GMBH for prostate specific membrane antigen (PSMA) ligands. The application details a compound of Formula (I) and its use in treating cancer.

Patent Application: Tumor Targeting Methods and Reagents

The USPTO has published a patent application (US20260083867A1) detailing methods and reagents for tumor targeting in cancer treatment. The application, filed on November 21, 2025, describes a combination therapeutic approach using agents with different biodistributions to enhance efficacy and reduce toxicity.

Patent Application: Compositions with Sophorolipids and Lactic Acid

The USPTO has published a new patent application (US20260083655A1) filed by Evonik Operations GmbH. The application describes compositions containing sophorolipids and lactic acid for cleaning or skin moisturizing. This is a routine filing for a new patent application.

Patent Application for Hyaluronic Acid Production Stimulation

The USPTO has published a new patent application (US20260083656A1) filed by Alastin Skincare, Inc. The application details compositions and methods for stimulating intrinsic hyaluronic acid production to improve skin moisture and elasticity. This is a routine publication of a patent application.

Patent Application for Whitening Cosmetic Composition with Artemisinic Acid

The USPTO has published a patent application (US20260083657A1) for a whitening cosmetic composition containing artemisinic acid, nicotinamide, and/or glutathione. The application, filed by Yunnan Botanee Bio-Technology Group Co., Ltd., describes a formulation designed to inhibit melanin production and reduce skin irritation.

Cleansing composition with carnosine, magnesium, caffeine

The USPTO has published a new patent application (US20260083658A1) for a personal cleansing composition. The composition includes carnosine, magnesium salt, caffeine, and transdermal absorption enhancers, designed for use in products like shower gels and soaps.